Richard A. Scolyer

Researcher Next ID · RN-004440

Researcher · Medicine

Sydney, Australia

Not currently recruitingFunding unknown

Research interests

Medicine

Biochemistry, Genetics and Molecular Biology

Immunology and Microbiology

Cutaneous Melanoma Detection and Management

Melanoma and MAPK Pathways

Cancer Immunotherapy and Biomarkers

Immunotherapy and Immune Responses

CAR-T cell therapy research

Distinct Immune Cell Populations Define Response to Anti-PD-1 Monotherapy and Anti-PD-1/Anti-CTLA-4 Combined Therapy
Cancer Cell · 2019 · https://doi.org/10.1016/j.ccell.2019.01.003
Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study
The Lancet Oncology · 2018 · https://doi.org/10.1016/s1470-2045(18)30139-6
Melanoma staging: Evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual
CA A Cancer Journal for Clinicians · 2017 · https://doi.org/10.3322/caac.21409
Whole-genome landscapes of major melanoma subtypes
Nature · 2017 · https://doi.org/10.1038/nature22071
Prognostic and Clinicopathologic Associations of Oncogenic BRAF in Metastatic Melanoma
Journal of Clinical Oncology · 2011 · https://doi.org/10.1200/jco.2010.32.4327

No projects listed.